TY - JOUR
T1 - Electrodermal activity in bipolar disorder
T2 - Differences between mood episodes and clinical remission using a wearable device in a real-world clinical setting
AU - Anmella, Gerard
AU - Mas, Ariadna
AU - Sanabra, Miriam
AU - Valenzuela-Pascual, Clàudia
AU - Valentí, Marc
AU - Pacchiarotti, Isabella
AU - Benabarre, Antoni
AU - Grande, Iria
AU - De Prisco, Michele
AU - Oliva, Vincenzo
AU - Fico, Giovanna
AU - Giménez-Palomo, Anna
AU - Bastidas, Anna
AU - Agasi, Isabel
AU - Young, Allan H
AU - Garriga, Marina
AU - Corponi, Filippo
AU - Li, Bryan M
AU - de Looff, Peter
AU - Vieta, Eduard
AU - Hidalgo-Mazzei, Diego
N1 - Funding Information:
GA is supported by a Rio Hortega 2021 grant ( CM21/00017 ) and M-AES mobility fellowship ( MV22/00058 ), from the Spanish Ministry of Health financed by the Instituto de Salud Carlos III (ISCIII) and cofinanced by Fondo Social Europeo Plus (FSE+).
Funding Information:
This project was funded by the ISCIII ( FIS PI21/00340 , TIMEBASE Study), cofunded by the European Union , as well as a Baszucki Brain Research Fund grant ( PI046998 ) from the Milken Foundation . The ISCIII or the Milken Foundation had no further role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.
Funding Information:
MS is supported by a grant from the Baszucki Brain Research Fund from the Milken Foundation .
Funding Information:
AGP is supported by a Rio Hortega 2021 grant ( CM21/00094 ) from the Spanish Ministry of Health financed by ISCIII and cofinanced by Fondo Social Europeo Plus (FSE+).
Funding Information:
IG thanks the support of the Spanish Ministry of Science and Innovation (PI19/00954) integrated into the Plan Nacional de I + D + I and cofinanced by the ISCIII-Subdirección General de Evaluación y el Fondos Europeos de la Unión Europea (FEDER, FSE, Next Generation EU/Plan de Recuperación Transformación y Resiliencia_PRTR); the ISCIII ; the CIBER of Mental Health (CIBERSAM); and the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement (2017 SGR 1365), Centres de Recerca de Catalunya (CERCA) Programme or Generalitat de Catalunya as well as the Fundació Clínic per la Recerca Biomèdica ( Pons Bartran 2022-FRCB_PB1_2022 ).
Funding Information:
GF received the support of a fellowship from “La Caixa” Foundation (ID 100010434 - fellowship code LCF/BQ/DR21/11880019).
Funding Information:
FC and BML are supported by the United Kingdom Research and Innovation (grant EP/S02431X/1 ), UK Research and Innovation (UKRI) Centre for Doctoral Training in Biomedical AI at the University of Edinburgh, School of Informatics.
Publisher Copyright:
© 2023 Elsevier B.V.
PY - 2024/1/15
Y1 - 2024/1/15
N2 - Background: Bipolar disorder (BD) lacks objective measures for illness activity and treatment response. Electrodermal activity (EDA) is a quantitative measure of autonomic function, which is altered in manic and depressive episodes. We aimed to explore differences in EDA (1) inter-individually: between patients with BD on acute mood episodes, euthymic states and healthy controls (HC), and (2) intra-individually: longitudinally within patients during acute mood episodes of BD and after clinical remission. Methods: A longitudinal observational study. EDA was recorded using a research-grade wearable in patients with BD during acute manic and depressive episodes and at clinical remission. Euthymic BD patients and HC were recorded during a single session. We compared EDA parameters derived from the tonic (mean EDA, mEDA) and phasic components (EDA peaks per minute, pmEDA, and EDA peaks mean amplitude, pmaEDA). Inter- and intra-individual comparisons were computed respectively with ANOVA and paired t-tests. Results: 49 patients with BD (15 manic, 9 depressed, and 25 euthymic), and 19 HC were included. Patients with bipolar depression showed significantly reduced mEDA (p = 0.003) and pmEDA (p = 0.001), which increased to levels similar to euthymia or HC after clinical remission (mEDA, p = 0.011; pmEDA, p < 0.001; pmaEDA, p < 0.001). Manic patients showed no differences compared to euthymic patients and HCs, but a significant reduction of tonic and phasic EDA parameters after clinical remission (mEDA, p = 0.035; pmEDA, p = 0.004). Limitations: Limited sample size, high inter-individual variability of EDA parameters, limited comparability to previous studies and non-adjustment for medication. Conclusion: EDA ecological monitoring might provide several opportunities for early detection of depressive symptoms, and might aid at assessing early response to treatments in mania and bipolar depression.
AB - Background: Bipolar disorder (BD) lacks objective measures for illness activity and treatment response. Electrodermal activity (EDA) is a quantitative measure of autonomic function, which is altered in manic and depressive episodes. We aimed to explore differences in EDA (1) inter-individually: between patients with BD on acute mood episodes, euthymic states and healthy controls (HC), and (2) intra-individually: longitudinally within patients during acute mood episodes of BD and after clinical remission. Methods: A longitudinal observational study. EDA was recorded using a research-grade wearable in patients with BD during acute manic and depressive episodes and at clinical remission. Euthymic BD patients and HC were recorded during a single session. We compared EDA parameters derived from the tonic (mean EDA, mEDA) and phasic components (EDA peaks per minute, pmEDA, and EDA peaks mean amplitude, pmaEDA). Inter- and intra-individual comparisons were computed respectively with ANOVA and paired t-tests. Results: 49 patients with BD (15 manic, 9 depressed, and 25 euthymic), and 19 HC were included. Patients with bipolar depression showed significantly reduced mEDA (p = 0.003) and pmEDA (p = 0.001), which increased to levels similar to euthymia or HC after clinical remission (mEDA, p = 0.011; pmEDA, p < 0.001; pmaEDA, p < 0.001). Manic patients showed no differences compared to euthymic patients and HCs, but a significant reduction of tonic and phasic EDA parameters after clinical remission (mEDA, p = 0.035; pmEDA, p = 0.004). Limitations: Limited sample size, high inter-individual variability of EDA parameters, limited comparability to previous studies and non-adjustment for medication. Conclusion: EDA ecological monitoring might provide several opportunities for early detection of depressive symptoms, and might aid at assessing early response to treatments in mania and bipolar depression.
UR - http://www.scopus.com/inward/record.url?scp=85174637470&partnerID=8YFLogxK
U2 - 10.1016/j.jad.2023.10.125
DO - 10.1016/j.jad.2023.10.125
M3 - Article
C2 - 37865347
SN - 0165-0327
VL - 345
SP - 43
EP - 50
JO - Journal of Affective Disorders
JF - Journal of Affective Disorders
ER -